Holen Sie sich die Stockscreener-App
0.7874
4.99%
0.0374
Handel nachbörslich:
.75
-0.0374
-4.75%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$0.75
Offen:
$0.769
24-Stunden-Volumen:
305.48K
Relative Volume:
3.02
Marktkapitalisierung:
$14.50M
Einnahmen:
$62.71M
Nettoeinkommen (Verlust:
$-10.48M
KGV:
-2.9163
EPS:
-0.27
Netto-Cashflow:
$-13.77M
1W Leistung:
+6.55%
1M Leistung:
-67.19%
6M Leistung:
-84.35%
1J Leistung:
-82.19%
1-Tages-Spanne:
$0.7276
$0.79
1-Wochen-Bereich:
$0.661
$0.793
52-Wochen-Spanne:
$0.6601
$7.48
Prophase Labs Inc Stock (PRPH) Company Profile
Firmenname
Prophase Labs Inc
Sektor
Branche
Telefon
(215) 345-0919
Adresse
711 STEWART AVE, SUITE 200, NEW YORK, PA
Vergleichen Sie PRPH mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
| PRPH | 0.7874 | 14.50M | 62.71M | -10.48M | -13.77M | -0.27 |
| TMO | 501.29 | 192.46B | 42.37B | 6.14B | 7.78B | 15.26 |
| DHR | 230.06 | 166.23B | 23.74B | 3.89B | 4.98B | 7.93 |
| A | 126.92 | 36.47B | 6.50B | 1.41B | 1.42B | 3.82 |
| IQV | 191.04 | 34.67B | 15.32B | 1.41B | 1.96B | 5.95 |
| IDXX | 419.83 | 34.38B | 3.84B | 866.24M | 792.60M | 9.80 |
Prophase Labs Inc Stock (PRPH) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2021-12-20 | Eingeleitet | H.C. Wainwright | Buy |
| 2021-10-13 | Herabstufung | Dawson James | Buy → Neutral |
| 2021-01-20 | Eingeleitet | Dawson James | Buy |
Prophase Labs Inc Aktie (PRPH) Neueste Nachrichten
ProPhase Labs Inc (PRPH) Q3 2024 Earnings Call Highlights: Strat - GuruFocus.com
Diamond Equity Research Releases Update Note on ProPhase Labs Inc. (NASDAQ: PRPH) - EIN News
ProPhase Labs, Inc. (NASDAQ:PRPH) Q3 2024 Earnings Call Transcript - Insider Monkey
Earnings call: Prophase Labs' Q3 2024 reveals strategic growth initiatives By Investing.com - Investing.com Australia
ProPhase Labs: Strategic Moves for Future Growth - TipRanks
ProPhase Labs, Inc. (PRPH) Reports Q3 Loss, Tops Revenue Estimates - Yahoo Finance
ProPhase Labs Announces Financial Results for the Three Months Ended September 30, 2024 - The Manila Times
ProPhase Labs Q3 Revenue Falls 63%, But Projects $15M+ Future Growth from Pharmaloz | PRPH Stock News - StockTitan
ProPhase Labs earnings missed by $0.04, revenue topped estimates - Investing.com Canada
ProPhase Labs Announces Closing of Public Offering of Common Stock - GlobeNewswire
ProPhase Labs plummets 21%, prices $3M equity offering - MSN
Wendys Company (WEN-Q) QuotePress Release - The Globe and Mail
Palantir Technologies Inc Cl A (PLTR-N) QuotePress Release - The Globe and Mail
ProPhase Labs Inc. to Present Third Quarter 2024 Financial Results on November 13, 2024 - GlobeNewswire
ProPhase Labs to Host Q3 2024 Earnings Call on November 13 | PRPH Stock | PRPH Stock News - StockTitan
ProPhase Labs announces proposed public offering of common stock - MSN
Investors Give ProPhase Labs, Inc. (NASDAQ:PRPH) Shares A 65% Hiding - Simply Wall St
It's Down 65% But ProPhase Labs, Inc. (NASDAQ:PRPH) Could Be Riskier Than It Looks - Simply Wall St
S&P 500 Tops 6,000; Sezzle Shares Spike Higher - Benzinga
Dow Tops 44,000; US Consumer Sentiment Increases In NovemberNature's Miracle Holding (NASDAQ:NMHI) - Benzinga
U.S. Stock market: FOXO Technologies(+134.66%) Northann Corp.(+67.38%) and ProPhase Labs(-47.43%) were the most volatile stocks during midday trading - Business Upturn
U.S. Stock market: Tivic Health up 138.62%, Northann surges 120.19%, ProPhase Labs down 50.70% among the most volatile stocks during early trading - Business Upturn
PRPHProPhase Labs, Inc. Latest Stock News & Market Updates - StockTitan
ProPhase Labs Prices of Public Offering of Common Stock - citybiz
ProPhase Labs Raises $3M in Public Offering at $0.72 Per Share, Stock Dilution Ahead | PRPH Stock News - StockTitan
ProPhase Labs Announces Pricing of Public Offering of Common Stock - GlobeNewswire
ProPhase Labs plans public stock offering - Investing.com India
Form FWP ProPhase Labs, Inc. Filed by: ProPhase Labs, Inc. - StreetInsider.com
ProPhase Labs Announces Proposed Public Offering of Common Stock - GlobeNewswire
ProPhase Labs stock hits 52-week low at $1.99 amid market challenges - Investing.com
ProPhase Labs Launches DNA Complete®: Transforming - GlobeNewswire
ProPhase Labs Launches DNA Complete®: Transforming Direct-to-Consumer Genetic Testing for Health, Wellness, and Enhanced Ancestry - StockTitan
ProPhase Labs to Present at the 2024 ThinkEquity Conference - GlobeNewswire
TSX Composite Index (TXCX) QuotePress Release - The Globe and Mail
Enphase Energy Inc (ENPH-Q) QuotePress Release - The Globe and Mail
ProPhase Labs projects significant 2025 earnings - Investing.com
ProPhase Labs Announces Positive Updates on Strategic - GlobeNewswire
ProPhase Labs Announces Positive Updates on Strategic Initiatives Company Anticipates Multiple Liquidity Events in H1 2025 - StockTitan
Down 34% and 57%, Wall Street Says These 2 Stocks Will Gain 230% - MSN
ProPhase Labs announces change in accounting firm - Investing.com India
ProPhase Labs announces change in accounting firm By Investing.com - Investing.com South Africa
* ProPhase Labs, Inc. Announces final results of its tender offer - Reuters
ProPhase Labs stock hits 52-week low at $2.02 By Investing.com - Investing.com Australia
ProPhase Labs reports non-compliance with Nasdaq rules By Investing.com - Investing.com South Africa
ProPhase Labs reports non-compliance with Nasdaq rules - Investing.com India
ProPhase Labs Seeks Director Amidst Nasdaq Compliance Issue - TipRanks
Priority Technology (NASDAQ:PRTH) Reaches New 1-Year High After Analyst Upgrade - MarketBeat
Primoris Services Co. (NASDAQ:PRIM) Shares Sold by Paradigm Capital Management Inc. NY - Defense World
PROCEPT BioRobotics Co. (NASDAQ:PRCT) Given Consensus Rating of “Buy” by Analysts - Defense World
Views of Wall Street’s Leading Experts on Proto Labs Inc - SETE News
Tri Locum Partners LP Trims Position in Praxis Precision Medicines, Inc. (NASDAQ:PRAX) - MarketBeat
Finanzdaten der Prophase Labs Inc-Aktie (PRPH)
Umsatz
Nettogewinn
Free Cashflow
ENV
5.04%
3.19%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):